Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Orient Pharma Co., Ltd. per 2025 Jun 30 adalah 1,262.29 MM.
- Nilai operating income untuk Orient Pharma Co., Ltd. per 2025 Jun 30 adalah 144.34 MM.
- Nilai net income untuk Orient Pharma Co., Ltd. per 2025 Jun 30 adalah 79.71 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 1,262.29 | 144.34 | 79.71 |
2025-03-31 | 1,263.77 | 171.64 | 119.94 |
2024-12-31 | 1,222.82 | 157.91 | 107.37 |
2024-09-30 | 1,144.24 | 150.97 | 113.23 |
2024-06-30 | 1,065.66 | 144.02 | 119.10 |
2024-03-31 | 952.24 | 71.90 | 60.19 |
2023-12-31 | 889.91 | 24.32 | 22.29 |
2023-09-30 | 766.96 | -16.98 | -12.90 |
2023-06-30 | 644.01 | -58.29 | -48.08 |
2023-03-31 | 577.93 | -50.01 | -38.42 |
2022-12-31 | 511.86 | -41.74 | -28.76 |
2022-09-30 | 544.14 | -26.06 | -25.06 |
2022-06-30 | 576.42 | -10.38 | -21.36 |
2022-03-31 | 519.88 | -71.93 | -62.01 |
2021-12-31 | 463.34 | -133.49 | -102.65 |
2021-09-30 | 451.11 | -176.18 | -170.03 |
2021-06-30 | 426.76 | -198.65 | -173.20 |
2021-03-31 | 419.39 | -182.70 | -172.29 |
2020-12-31 | 412.01 | -166.75 | -171.38 |
2020-09-30 | 411.70 | -154.97 | -162.20 |
2020-06-30 | |||
2020-03-31 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | 0.53 | 0.53 |
2024-03-31 | 0.32 | 0.32 |
2023-12-31 | 0.10 | |
2023-09-30 | -0.06 | -0.06 |
2023-06-30 | -0.23 | -0.23 |
2023-03-31 | -0.20 | -0.20 |
2022-12-31 | -0.15 | |
2022-09-30 | -0.13 | -0.13 |
2022-06-30 | -0.11 | -0.11 |
2022-03-31 | -0.33 | -0.33 |
2021-12-31 | -0.55 | |
2021-09-30 | -0.91 | -0.91 |
2021-06-30 | -0.94 | -0.94 |
2021-03-31 | -0.97 | -0.97 |
2020-12-31 | -1.01 | |
2020-09-30 | -1.00 | -1.00 |
2020-06-30 | -1.13 | -1.13 |
2020-03-31 | -1.21 | -1.21 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Orient Pharma Co., Ltd. per 2025 Jun 30 adalah 254.60 MM.
- Nilai cash from investing activities untuk Orient Pharma Co., Ltd. per 2025 Jun 30 adalah -3.71 MM.
- Nilai kas dari aktivitas pendanaan untuk Orient Pharma Co., Ltd. per 2025 Jun 30 adalah -190.35 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | 254.60 | -3.71 | -190.35 |
2025-03-31 | 309.28 | -6.27 | -190.21 |
2024-12-31 | 197.01 | -22.48 | -173.36 |
2024-09-30 | 183.87 | -30.71 | -122.29 |
2024-06-30 | 170.73 | -38.94 | -71.21 |
2024-03-31 | -21.03 | -62.51 | 88.19 |
2023-12-31 | -102.99 | -88.02 | 197.90 |
2023-09-30 | -133.30 | -81.14 | 198.03 |
2023-06-30 | -163.61 | -74.26 | 198.17 |
2023-03-31 | -76.11 | -51.67 | 80.69 |
2022-12-31 | 11.38 | -29.09 | -36.79 |
2022-09-30 | 40.38 | 6.12 | -33.13 |
2022-06-30 | 69.38 | 41.33 | -29.46 |
2022-03-31 | 7.91 | 48.57 | 24.82 |
2021-12-31 | -53.56 | 55.81 | 79.11 |
2021-09-30 | -109.98 | -33.45 | 135.56 |
2021-06-30 | -159.67 | -189.99 | 374.72 |
2021-03-31 | -153.81 | -192.29 | 364.79 |
2020-12-31 | -147.95 | -194.60 | 354.85 |
2020-09-30 | -125.74 | -135.87 | 337.89 |
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 | |||
2020-06-30 | |||
2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 | ||
2020-06-30 | ||
2020-03-31 |
Efektivitas Manajemen
- roa untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.04.
- roe untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.05.
- roic untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.05.
- croic untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.00.
- ocroic untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.08.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | 0.04 | 0.05 | 0.05 | 0.00 | 0.08 |
2025-03-31 | 0.04 | 0.07 | 0.05 | 0.00 | 0.08 |
2024-12-31 | 0.05 | 0.06 | 0.05 | 0.02 | 0.07 |
2024-09-30 | 0.04 | 0.07 | 0.05 | 0.02 | 0.07 |
2024-06-30 | 0.01 | 0.04 | 0.01 | 0.00 | -0.04 |
2024-03-31 | -0.03 | 0.02 | |||
2023-12-31 | -0.03 | -0.04 | -0.01 | -0.01 | -0.06 |
2023-09-30 | -0.03 | -0.04 | -0.02 | -0.02 | -0.07 |
2023-06-30 | -0.02 | -0.04 | -0.02 | -0.02 | -0.08 |
2023-03-31 | -0.02 | -0.03 | -0.02 | -0.02 | -0.04 |
2022-12-31 | -0.01 | -0.02 | -0.02 | 0.01 | 0.03 |
2022-09-30 | -0.01 | -0.02 | -0.02 | 0.01 | 0.03 |
2022-06-30 | -0.06 | -0.02 | -0.01 | 0.05 | 0.04 |
2022-03-31 | 0.00 | 0.00 | 0.00 | 0.07 | 0.01 |
2021-12-31 | -0.10 | -0.14 | -0.07 | 0.05 | -0.10 |
2021-09-30 | -0.10 | -0.13 | -0.11 | -0.01 | -0.10 |
2021-06-30 | -0.11 | -0.19 | -0.12 | 0.02 | -0.11 |
2021-03-31 | -0.11 | -0.19 | -0.11 | 0.01 | -0.10 |
2020-12-31 | -0.11 | -0.17 | -0.11 | 0.01 | -0.10 |
2020-09-30 | -0.10 | -0.15 | -0.10 | 0.05 | -0.08 |
2020-06-30 | -0.11 | -0.16 | -0.15 | -0.02 | -0.10 |
2020-03-31 | -0.12 | -0.17 | -0.14 | -0.01 | -0.09 |
Gross Margins
- marjin kotor untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.53.
- marjin bersih untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.09.
- marjin operasi untuk Orient Pharma Co., Ltd. pada 2025 Jun 30 adalah 0.13.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.53 | 0.09 | 0.13 |
2025-03-31 | 0.53 | 0.09 | 0.13 |
2024-12-31 | 0.55 | 0.11 | 0.14 |
2024-09-30 | 0.55 | 0.11 | 0.14 |
2024-06-30 | 0.53 | 0.03 | 0.03 |
2024-03-31 | 0.42 | -0.07 | -0.09 |
2023-12-31 | 0.42 | -0.07 | -0.09 |
2023-09-30 | 0.42 | -0.07 | -0.09 |
2023-06-30 | 0.30 | -0.07 | -0.09 |
2023-03-31 | 0.30 | -0.07 | -0.09 |
2022-12-31 | 0.36 | -0.05 | -0.05 |
2022-09-30 | 0.36 | -0.05 | -0.05 |
2022-06-30 | 0.31 | -0.04 | -0.02 |
2022-03-31 | 0.34 | 0.00 | -0.14 |
2021-12-31 | 0.24 | -0.22 | -0.29 |
2021-09-30 | 0.24 | -0.38 | -0.39 |
2021-06-30 | 0.24 | -0.41 | -0.47 |
2021-03-31 | 0.21 | -0.41 | -0.44 |
2020-12-31 | 0.18 | -0.42 | -0.40 |
2020-09-30 | 0.14 | -0.39 | -0.38 |
2020-06-30 | 0.09 | -0.46 | -0.44 |
2020-03-31 | 0.06 | -0.51 | -0.51 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |